Sign up now and fund within 24h to get A$10.
Claim It Now
Stake logo

Betashares Global Healthcare ETF - Currency Hedged

1 day chart

Get A$10 trading credit to start you off

Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.

Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.

T&Cs apply
Claim now
Get A$10 trading credit to start you off

About DRUG

Betashares Global Healthcare ETF -Currency Hedged (DRUG) provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector. The Fund aims to track the performance of an index (before fees and expenses) which provides exposure to the performance of the largest global healthcare companies by market capitalization (excluding companies in Australia), hedged into Australian dollars.

Buy Australian shares starting with DRUG. Invest today with a CHESS-sponsored investing platform!

Sector

-

CEO

-

Industry

-

Market Capitalisation

$164M

Price-earnings ratio

110.92

Dividend yield

0.23%

High today

$8.32

Low today

$8.28

Open price

$8.28

52-week high

$8.70

52-week low

$7.30


Announcements





What is DRUG stock?

DRUG is an exchange-traded fund that invests in large-cap healthcare companies outside of Australia, both directly and through foreign currency forward contracts. 

Also known as BetaShares Global Healthcare ETF - Currency Hedged, DRUG is actively managed by BetaShares Capital Limited. It seeks to replicate the behaviour of the Nasdaq Global ex-Australia Healthcare Hedged AUD Index by investing in companies as per their weight in the index. DRUG’s returns are hedged to the Australian dollar.

Why is DRUG a currency-hedged ETF?

DRUG ETF is denominated in Australian dollars but equities within the fund are in foreign currencies.

By currency hedging, BetaShares locks down a set exchange rate for the future and lowers the effects and risks of exchange rate fluctuations on investments within DRUG.

How do I buy DRUG stock?

Stake offers a quick and easy way to purchase the DRUG ETF – along with 2,000+ other Australian stocks and ASX ETFs – for a brokerage fee of only A$3.

Stake is CHESS sponsored, meaning that when you invest in ASX stocks, you get a HIN (Holder Identification Number) and stocks are held in your name.

With Stake, you can be in the market in under 5 minutes, whether it's the ASX or Wall St. If you’re interested in building your portfolio by adding DRUG, sign up today.

Which stocks are in the DRUG ETF?

73.9% of DRUG is allocated to American healthcare stocks. Swiss, British, Japanese and Danish healthcare companies are also sizeable allocations at 9.4%, 4.9%, 3.3% and 3.2%, respectively.

Some of DRUG’s most prominent holdings include UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), Pfizer Inc. (PFE), Roche (ROG), Eli Lilly & Company (LLY), Thermo Fisher Scientific (TMO), AstraZeneca (AZN), Novo Nordisk (NOVO-B) and Takeda Pharmaceutical Company (4502).

For a complete list of DRUG’s current holdings, click here.

Does DRUG pay a distribution?

Yes. As of 31 March 2022, DRUG stock’s distribution yield is 4.7%.

In FY2021, Betashares paid out a total of A$0.36644 per share. Historically, distributions have been paid twice a year, usually in January and July.

Is DRUG a good buy?

DRUG may be an appropriate buy for investors seeking quick, simple and cost-effective access to the world’s biggest healthcare companies. By purchasing DRUG, investors do not need to purchase individual healthcare stocks.

ETFs are usually considered long-term passive investments and the DRUG ETF is no exception. The fund has a low management cost of 0.57% p.a. In FY2021, the DRUG stock price achieved 22.34% growth.

Ready to start your investing journey with Stake?

Open an account

DRUG FAQs

Yes, the Stake platform allows you to buy DRUG shares and over 12,000 stocks and ETFs across the ASX and Wall St.

One share of Betashares Global Healthcare ETF - Currency Hedged is valued at $8.31.

The ticker symbol for Betashares Global Healthcare ETF - Currency Hedged is DRUG.

To buy DRUG stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:
  1. Sign up in minutes, all you need is some I.D.
  2. Choose Stake AUS
  3. Deposit directly into your Stake wallet and you're ready to invest in DRUG

The Betashares Global Healthcare ETF - Currency Hedged 52-week high stock price is $8.70.

The Betashares Global Healthcare ETF - Currency Hedged 52-week low stock price is $7.30.

As of 23/04/2024 Betashares Global Healthcare ETF - Currency Hedged has a market cap of $164M.

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in DRUG
on Stake

Buy DRUG from AU$3 brokerage

Invest in 2,500+ Aussie stocks and ETFs

CHESS-sponsored ASX trades

Get started
Canstar award phone
DRUG related stocks

Stake logo
Over 7,000 5-star reviews
App Store logoGoogle Play logo

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.

Stakeshop Pty Ltd, trading as Stake, ACN 610105505, is an authorised representative (Authorised Representative No. 1241398) of Sanlam Private Wealth Pty Ltd (Australian Financial Services Licence No. 337927) ('Sanlam') and an authorised representative (Authorised Representative No. 1241398) of Airwallex Pty Ltd (Australian Financial Services Licence No. 487221) ('Airwallex'). Stake is not authorised by Airwallex under Airwallex’s AFSL to arrange for clients to be issued with securities as Airwallex is not authorised under its AFSL for this purpose. Stake is not authorised by Sanlam under Sanlam’s AFSL to arrange for clients to be issued with a non-cash payment facility as Sanlam is not authorised under its AFSL for this purpose. Stake SMSF Pty Ltd (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. Stakeshop Pty Ltd will also run marketing and promotions to you under. For more information about SMSFs, see our SMSF Risks page.The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services GuideTerms & ConditionsPrivacy Policy and Disclaimers  before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2024 Stake. All rights reserved.